Direxion Daily S&P Biotech Bear 1X ETF (LABS) Analysis

このページは英語の原文からAIによって機械翻訳されています。英語版が正式なものです。英語版を読む

情報提供のみを目的としています。投資助言ではありません。

Direxion Daily S&P Biotech Bear 1X ETF (LABS) ETF — Price, Holdings & Analysis

ETF概要

Direxion Daily S&P Biotech Bear 1X ETF provides exposure to the equity market. Direxion Daily S&P Biotech Bear 1X ETF invests across equity markets, providing investors with diversified exposure to this asset class through a single, exchange-traded vehicle. As an exchange-traded fund, it offers the benefits of intraday liquidity, transparent holdings, and generally lower costs compared to traditional mutual fund structures.

リスク指標

As with all ETFs, the fund is subject to market risk and its value will fluctuate with market conditions. Past performance does not guarantee future results. The fund's investment objectives, risks, charges, and expenses may be worth researching before investing.

iShares Morningstar Small-Cap Growth ETF (JKK) — 0.06% expense ratio
ARK Innovation ETF (ARKK) — 0.75% expense ratio
Invesco QQQ Trust, Series 1 (QQQ) — 0.18% expense ratio
State Street Energy Select Sector SPDR ETF (XLE) — 0.08% expense ratio
WisdomTree Emerging Markets ESG Fund (DVEM) — 0.32% expense ratio
Goldman Sachs ActiveBeta Emerging Markets Equity ETF (GEM) — 0.59% expense ratio
State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) — 0.16% expense ratio
State Street Technology Select Sector SPDR ETF (XLK) — 0.08% expense ratio

Direxion MSCI Developed Over Emerging Markets ETF (RWDE) (Equity) — 0.53% expense ratio
Direxion Russell Small Over Large Cap ETF (RWSL) (Equity) — 0.59% expense ratio
Direxion Daily XOM Bull 2X ETF (XOMX) (Equity) — 2.36% expense ratio
Direxion Daily Uranium Industry Bull 2X ETF (URAA) (Equity) — 1.46% expense ratio
Direxion Daily Global Clean Energy Bull 2X Shares (KLNE) (Equity) — 1.33% expense ratio
Direxion Daily AMD Bull 2X ETF (AMUU) (Equity) — 1.16% expense ratio

よくある質問

How long has LABS been around?

Direxion Daily S&P Biotech Bear 1X ETF was launched in 2015, making it 11 years old. With over a decade of history, it has navigated various market conditions.

Is LABS a good investment?

Direxion Daily S&P Biotech Bear 1X ETF is a equity ETF. Equity ETFs are subject to market risk and can experience significant short-term volatility, though they have historically provided strong long-term returns for patient investors.

Whether it is suitable depends on your investment goals, risk tolerance, and time horizon. Consider consulting a financial advisor for personalized guidance.

免責事項：このコンテンツは情報提供のみを目的としており、投資助言を構成するものではありません。常に独自の調査を行い、ファイナンシャルアドバイザーにご相談ください。

データは情報提供のみを目的として提供されています。

本ページは機械が作成しており、1ページずつの人手レビューは行っていません。編集上の管理は仕組みとして行っています（ルールと出典を点検し、個々のページは点検していません）。